Table 2.
Patients with confirmed COVID-19 | Control group | p value | |
---|---|---|---|
Patient number, n (%) | 100 (100) | 269 (100) | - |
Age, years (IQR) | 13.3 (8–15.4) | 10.1 (5.1–14.5) | 0.006 |
Sex, n (%) | 0.982 | ||
Girl | 56 (56) | 151 (56.1) | |
Boy | 44 (44) | 118 (43.9) | |
Serum zinc, median (IQR) (ng/mL) | 88.5 (77.2–100) | 98 (84–111) | 0.001 |
Patient numbers according to serum levels of zinc, n (%) | 0.623 | ||
Serum levels of zinc < 70 | 11 (11) | 25 (9.3) | |
Serum levels of zinc > 70 | 89 (89) | 244 (90.7) | |
Patient number according to months, n (%) | <0.001 | ||
August | 35 (35) | 119 (44.2) | |
September | 31 (31) | 61 (22.7) | |
October | 21 (21) | 88 (32.7) | |
November | 13 (13) | 1 (0.4) |